Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis

Background. Interleukin-37b is a fundamental inhibitor of innate and acquired immunity. Type 2 innate lymphoid cells (ILC2s) can secret type 2 cytokines and regulate allergic rhinitis (AR). However, the role of IL-37b in ILC2s in children with AR was not clear. Methods. We recruited 15 AR children a...

Full description

Bibliographic Details
Main Authors: Qingxiang Zeng, Yinhui Zeng, Haiqing Xiao, Jinyuan Li, Chao Yang, Renzhong Luo, Wenlong Liu, Yanhui Wen
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2023/1572891
_version_ 1797842546100011008
author Qingxiang Zeng
Yinhui Zeng
Haiqing Xiao
Jinyuan Li
Chao Yang
Renzhong Luo
Wenlong Liu
Yanhui Wen
author_facet Qingxiang Zeng
Yinhui Zeng
Haiqing Xiao
Jinyuan Li
Chao Yang
Renzhong Luo
Wenlong Liu
Yanhui Wen
author_sort Qingxiang Zeng
collection DOAJ
description Background. Interleukin-37b is a fundamental inhibitor of innate and acquired immunity. Type 2 innate lymphoid cells (ILC2s) can secret type 2 cytokines and regulate allergic rhinitis (AR). However, the role of IL-37b in ILC2s in children with AR was not clear. Methods. We recruited 15 AR children and controls. The serum IL-37b levels and its relation with the frequency and functional phenotype of ILC2s. The regulation of IL-37b on ILC2s proliferation and function was confirmed using flow cytometry and enzyme-linked immunosorbent assay (ELISA). The mRNA expression of IL-1R8, IL-18Rα, and ICOSL was examined using RCR. The change of IL-37b protein level in serum during subcutaneous allergen immunotherapy (SCIT) was determined by ELISA. Results. We have demonstrated that both of the frequencies of blood ILC2s, IL-5+ILC2s, and IL-13+ILC2s in AR children were elevated compared with controls. The serum protein level of IL-37b was downregulated in AR, and it was negatively related to the frequency of ILC2s, IL-5+ILC2s, and IL-13+ILC2s. IL-37b increased the mRNA levels of IL-1R8, IL-18Rα, and ICOSL expressed by ILC2s. IL-37b suppressed the proliferation of ILC2s and the secretion of IL-5 and IL-13 from ILC2s. Finally, we found that IL-37b was increased in AR children after 3 years’ SLIT, especially in the good response group. Conclusion. Our findings highlight the role of IL-37b in the suppression of ILC2s and establish a new therapeutic target in AR.
first_indexed 2024-04-09T16:49:40Z
format Article
id doaj.art-fa8f74300aa04715a3ad383f35f0e7e2
institution Directory Open Access Journal
issn 1466-1861
language English
last_indexed 2024-04-09T16:49:40Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Mediators of Inflammation
spelling doaj.art-fa8f74300aa04715a3ad383f35f0e7e22023-04-22T00:07:15ZengHindawi LimitedMediators of Inflammation1466-18612023-01-01202310.1155/2023/1572891Interleukin-37b Suppressed ILC2s in Children with Allergic RhinitisQingxiang Zeng0Yinhui Zeng1Haiqing Xiao2Jinyuan Li3Chao Yang4Renzhong Luo5Wenlong Liu6Yanhui Wen7Department of OtolaryngologyDepartment of OtolaryngologyDepartment of OtolaryngologyDepartment of OtolaryngologyDepartment of OtolaryngologyDepartment of OtolaryngologyDepartment of OtolaryngologyThe Third People’s Hospital of DongguanBackground. Interleukin-37b is a fundamental inhibitor of innate and acquired immunity. Type 2 innate lymphoid cells (ILC2s) can secret type 2 cytokines and regulate allergic rhinitis (AR). However, the role of IL-37b in ILC2s in children with AR was not clear. Methods. We recruited 15 AR children and controls. The serum IL-37b levels and its relation with the frequency and functional phenotype of ILC2s. The regulation of IL-37b on ILC2s proliferation and function was confirmed using flow cytometry and enzyme-linked immunosorbent assay (ELISA). The mRNA expression of IL-1R8, IL-18Rα, and ICOSL was examined using RCR. The change of IL-37b protein level in serum during subcutaneous allergen immunotherapy (SCIT) was determined by ELISA. Results. We have demonstrated that both of the frequencies of blood ILC2s, IL-5+ILC2s, and IL-13+ILC2s in AR children were elevated compared with controls. The serum protein level of IL-37b was downregulated in AR, and it was negatively related to the frequency of ILC2s, IL-5+ILC2s, and IL-13+ILC2s. IL-37b increased the mRNA levels of IL-1R8, IL-18Rα, and ICOSL expressed by ILC2s. IL-37b suppressed the proliferation of ILC2s and the secretion of IL-5 and IL-13 from ILC2s. Finally, we found that IL-37b was increased in AR children after 3 years’ SLIT, especially in the good response group. Conclusion. Our findings highlight the role of IL-37b in the suppression of ILC2s and establish a new therapeutic target in AR.http://dx.doi.org/10.1155/2023/1572891
spellingShingle Qingxiang Zeng
Yinhui Zeng
Haiqing Xiao
Jinyuan Li
Chao Yang
Renzhong Luo
Wenlong Liu
Yanhui Wen
Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
Mediators of Inflammation
title Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
title_full Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
title_fullStr Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
title_full_unstemmed Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
title_short Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
title_sort interleukin 37b suppressed ilc2s in children with allergic rhinitis
url http://dx.doi.org/10.1155/2023/1572891
work_keys_str_mv AT qingxiangzeng interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT yinhuizeng interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT haiqingxiao interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT jinyuanli interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT chaoyang interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT renzhongluo interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT wenlongliu interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis
AT yanhuiwen interleukin37bsuppressedilc2sinchildrenwithallergicrhinitis